This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sandri, M. T.
Right arrow Articles by Sideri, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sandri, M. T.
Right arrow Articles by Sideri, M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2006, p. 2141-2146, Vol. 44, No. 6
0095-1137/06/$08.00+0     doi:10.1128/JCM.00049-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Comparison of the Digene HC2 Assay and the Roche AMPLICOR Human Papillomavirus (HPV) Test for Detection of High-Risk HPV Genotypes in Cervical Samples

Maria T. Sandri,1* Paola Lentati,1 Elvira Benini,2 Patrizia Dell'Orto,2 Laura Zorzino,1 Francesca M. Carozzi,3 Patrick Maisonneuve,4 Rita Passerini,1 Michela Salvatici,1 Chiara Casadio,2 Sara Boveri,5 and Mario Sideri5

Laboratory Medicine Unit, European Institute of Oncology, Milan, Italy,1 Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy,2 Analytical Cytology and Biomolecular Unit, CSPO, Scientific Institute of Tuscany, Florence, Italy,3 Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy,4 Preventive Gynecology Unit, European Institute of Oncology, Milan, Italy5

Received 10 January 2006/ Returned for modification 24 February 2006/ Accepted 29 March 2006

Many different methods with different sensitivity and specificity have been proposed to detect the presence of high-risk human papillomavirus (HR HPV) in cervical samples. The HC2 is one of the most widely used. Recently, a new standardized PCR-based method, the AMPLICOR HPV test, has been introduced. Both assays recognize the same 13 HR HPV genotypes. The performances of these two commercially available assays were compared in 167 consecutive women (for a total of 168 samples) who presented at the Colposcopy Clinic either for a follow-up or for a diagnostic visit. Concordant results were found in 140/168 cervical samples (overall agreement, 83%; Cohen's kappa = 0.63). Twenty-eight samples gave discordant results: 20 were positive with the AMPLICOR HPV test and negative with the HC2 assay, and 8 were negative with the AMPLICOR HPV test and positive with the HC2 assay. The genotyping showed that no HR HPV was detected in the 8 HC2 assay-positive AMPLICOR HPV test-negative samples, while in 8/20 AMPLICOR HPV test-positive HC2 assay-negative samples, an HR HPV genotype was found. The AMPLICOR HPV test scored positive in a significantly higher percentage of subjects with normal Pap smears. All 7 cervical intraepithelial neoplasia grade 3 patients scored positive with the AMPLICOR HPV test, while 2 of them scored negative with HC2. Both tests had positive results in the only patient with squamous cell carcinoma. In conclusion, this study shows that the HC2 assay and the AMPLICOR HPV test give comparable results, with both being suitable for routine use. The differences noted in some cases may suggest a different optimal clinical use.

* Corresponding author. Mailing address: Laboratory Medicine Unit, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. Phone: 390257489422. Fax: 390257489417. E-mail: maria.sandri{at}ieo.it.

Journal of Clinical Microbiology, June 2006, p. 2141-2146, Vol. 44, No. 6
0095-1137/06/$08.00+0     doi:10.1128/JCM.00049-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Flatley, J. E., McNeir, K., Balasubramani, L., Tidy, J., Stuart, E. L., Young, T. A., Powers, H. J. (2009). Folate Status and Aberrant DNA Methylation Are Associated With HPV Infection and Cervical Pathogenesis. Cancer Epidemiol. Biomarkers Prev. 18: 2782-2789 [Abstract] [Full Text]  
  • Garcia-Sierra, N., Martro, E., Castella, E., Llatjos, M., Tarrats, A., Bascunana, E., Diaz, R., Carrasco, M., Sirera, G., Matas, L., Ausina, V. (2009). Evaluation of an Array-Based Method for Human Papillomavirus Detection and Genotyping in Comparison with Conventional Methods Used in Cervical Cancer Screening. J. Clin. Microbiol. 47: 2165-2169 [Abstract] [Full Text]  
  • Grisaru, D., Avidor, B., Niv, J., Marmor, S., Almog, B., Leibowitz, C., Graidy, M., Giladi, M. (2008). Pilot Study of Prevalence of High-Risk Human Papillomavirus Genotypes in Israeli Jewish Women Referred for Colposcopic Examination. J. Clin. Microbiol. 46: 1602-1605 [Abstract] [Full Text]  
  • Stevens, M. P., Garland, S. M., Rudland, E., Tan, J., Quinn, M. A., Tabrizi, S. N. (2007). Comparison of the Digene Hybrid Capture 2 Assay and Roche AMPLICOR and LINEAR ARRAY Human Papillomavirus (HPV) Tests in Detecting High-Risk HPV Genotypes in Specimens from Women with Previous Abnormal Pap Smear Results. J. Clin. Microbiol. 45: 2130-2137 [Abstract] [Full Text]  
  • Castle, P. E., Sadorra, M., Garcia, F. A.R., Cullen, A. P., Lorincz, A. T., Mitchell, A. L., Whitby, D., Chuke, R., Kornegay, J. R. (2007). Mouthwash as a Low-Cost and Safe Specimen Transport Medium for Human Papillomavirus DNA Testing of Cervicovaginal Specimens. Cancer Epidemiol. Biomarkers Prev. 16: 840-843 [Abstract] [Full Text]  
  • Payan, C., Ducancelle, A., Aboubaker, M. H., Caer, J., Tapia, M., Chauvin, A., Peyronnet, D., Le Hen, E., Arab, Z., Legrand, M.-C., Tran, A., Postec, E., Tourmen, F., Avenel, M., Malbois, C., De Brux, M.-A., Descamps, P., Lunel, F. (2007). Human Papillomavirus Quantification in Urine and Cervical Samples by Using the Mx4000 and LightCycler General Real-Time PCR Systems. J. Clin. Microbiol. 45: 897-901 [Abstract] [Full Text]  
  • Carozzi, F., Bisanzi, S., Sani, C., Zappa, M., Cecchini, S., Ciatto, S., Confortini, M. (2007). Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 Assay in Detection of High-Risk Human Papillomavirus and Diagnosis of Biopsy-Confirmed High-Grade Cervical Disease. J. Clin. Microbiol. 45: 364-369 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»